Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

Input: Consider Input: Paragraph: "The story covers cost in the very last two lines. Adequate quantification of benefits seen in the study. Story says ""few eye-related complications"" were reported in the Lucentis group, but didn’t say what few means or what they were. We don’t think that’s quite adequate. Adequate job explaining how the study was done and what it means. No disease mongering in the story. One quote from the head of the National Eye Institute. But he didn’t really evaluate evidence – only talked about hope. Meantime, no mention that Genentech funded  the trial (a strength of the NYT story was its discussion of the ""pay for play"" aspect of the research) – and no mention that Dr. Bressler disclosed financial ties to Genentech. From the Times: Some doctors criticized the organizers of the trial for testing Lucentis rather than another Genentech drug, Avastin, which works in the same way as Lucentis. Although it is a cancer drug, Avastin is often used off-label for eye diseases because it is far cheaper than Lucentis, costing only $20 to $100 a dose, compared with $2,000 for Lucentis. Avastin is undercutting sales of Lucentis, which totaled $1.1 billion in the United States last year. Organizers of the trial conceded that a major reason Lucentis was chosen was that Genentech, which is now owned by Roche, agreed to provide the drug free of charge and to contribute $9 million in additional financing — but only if Lucentis were used. “Obviously you can’t underplay $9 million,” said Dr. Ferris of the eye institute, which is part of the part of the National Institutes of Health. But he said there were other factors as well, like a belief that Lucentis might have been the better drug. Dr. Philip J. Rosenfeld, a professor of ophthalmology at the University of Miami, said the decision was “clearly a case of pay to play” since Genentech’s money dictated the choice of drugs. At least the story mentioned the uncertainty about whether Lucentis is any better  than the cheaper Avastin, and mentioned an upcoming trial comparing the two in age-related macular degeneration. The story explains that Lucentis was approved 4 years ago for another cause. Story explains the drug is already approved for another use, and it also – at the very end – mentions that an older and much cheaper drug is also effective. It’s clear the story did not rely on a news release." Claim: Drug Reverses Diabetes-Related Vision Loss

Output: The key difference between this and the NYT story was that WebMD didn’t reflect on the question of why Genentech didn’t test its cheaper Avastin against the much more expensive Lucentis. The important issue of corporate sponsorship of a clinical trial was overlooked. You want to talk about comparative effectiveness research? This would have been a good place for it.


Input: Consider Input: Paragraph: The 60-year-old sports fan, a surgeon who started and sold two pharmaceutical companies for a combined $8.6 billion, told Reuters in an interview this week that he wants to use Anschutz concert tours and sports events, and his NFL team’s players, to encourage L.A. school children to adopt healthier lifestyles. “The NFL can do so much for this city,” said Soon-Shiong in an interview at his west Los Angeles office. “Kids really rally around sports and entertainment and it could be a major catalyst to demonstrate what you can do in life by living better.”  Soon-Shiong grew up in South Africa, where he became a doctor in his early 20s and treated tuberculosis victims. After moving to the United States and becoming a surgeon at UCLA, he developed innovative methods to treat diabetes and cancer patients. The sale of his two companies for $8.6 billion made him the wealthiest person in Los Angeles, according to Forbes magazine, although he still is not a household name in the city. Under his plan, players would serve as mentors, encouraging students to eat better and exercise more. The most sophisticated methods used to deal with sports injuries could be shared with local doctors. “It’s important to motivate students in middle and high school. That’s when you can help reduce diabetes and obesity that cause illness,” he said. “Maybe we can turn that illness to wellness.”  If he’s successful in L.A., Soon-Shiong said he intends to make it a national program. Sources say the billionaire is assembling a group of other Los Angeles business and civic leaders to buy AEG. Soon-Shiong did not discuss details of his bid. Sources also said his buyer group includes private equity firm Guggenheim Partners, which this spring led a group that bought the Los Angeles Dodgers baseball team for $2 billion. AEG, which is owned by Denver billionaire Phil Anschutz, said on September 19 it had hired Blackstone Advisory Partners to sell the company. It is expected to fetch $6 billion to $8 billion, according to investment bankers with knowledge of its assets. Separately, Los Angeles for years has wanted to bring back a professional football team, and Soon-Shiong acknowledged that he has met with the NFL to lay out his plan to buy a team. AEG owns the Los Angeles Kings pro hockey franchise, the L.A. Galaxy soccer club and a 20 percent stake in the Los Angeles Lakers basketball team. It owns or operates sports and entertainment arenas worldwide, including the Staples Center in Los Angeles, and promotes concerts and other live action events. Soon-Shiong’s family foundation has committed $1 billion to transform healthcare and intends to create a national health superhighway by which doctors can share biotech information and other data to improve diagnosis and care. His foundation gave $135 million to the Saint John’s Health Center in Santa Monica and $100 million to reopen Martin Luther King Hospital, which serves lower income patients in south Los Angeles. A basketball fan who played in pickup games until tearing his Achilles tendon three years ago, Soon-Shiong owns a 5 percent stake in the Lakers, and he said he has become friends with superstar Kobe Bryant and other players, whom he sees as role models for young fans. In March, he and his actress wife, Michelle Chan, endowed the Chan Soon-Shiong Center for Sports Science at Saint John’s, which will focus on sports medicine, physical therapy and stem cell research to help heal injuries. It works with sports medicine doctors, including the Kerlan-Jobe Orthopedic Clinic that treats the Kings, Lakers and L.A. Dodgers. Saint John’s announced the sports science center at a dinner honoring AEG president Tim Leiweke in March, six months before Soon-Shiong showed his interest in the conglomerate. Claim: LA billionaire covets sports teams to promote health.

Output: Bio-tech entrepreneur Patrick Soon-Shiong, the richest man in Los Angeles, intends to make a bid for sports and real estate firm Anschutz Entertainment Group and wants to bring a National Football League team back to the second most populous U.S. city.


Input: Consider Input: Paragraph: Iran’s death toll from coronavirus rose to 2,517 on Saturday, with 139 fatalities in the past 24 hours, as cases rose 3,076 to 35,408, Health Ministry spokesman Kianoush Jahanpour said on state television. “We are in difficult conditions, in conditions of sanctions but we have allocated 20% of our budget this year to corona, ... and this might be surprising for the world from a country under sanctions,” Rouhani said in comments broadcast on state TV. Shut out of international capital markets and facing a further hit to its finances with the collapse in oil prices coming on top of U.S. sanctions, Iran is struggling to shield its economy from the coronavirus pandemic. Rouhani reassured the public that the country had a strong healthcare system able to cope should there be a rapid progression of the disease. The state health insurance would cover 90% of coronavirus-linked costs of patients, he said. The budget allocation, amounting to about 1,000 trillion rials, would include grants and low-interest loans to those affected by COVID-19, Rouhani said. The allocated amount is worth some $6.3 billion at the rial’s free market exchange rate of about 160,000 rials per dollar. But the government may decide to allocate some of the funds at the official rate of 42,000 which is used to subsidize food and medicine  On Thursday, Rouhani said the government was seeking approval to withdraw $1 billion from Iran’s sovereign wealth fund for the fight against coronavirus. Tapping the sovereign fund requires the agreement of Supreme Leader Ayatollah Ali Khamenei, who has the last say on all state matters. Tensions have risen between Iran and the United States since 2018, when U.S. President Donald Trump exited Tehran’s 2015 nuclear deal with world powers and reimposed sanctions that have crippled Iran’s economy. Iranian authorities, blaming U.S. sanctions for hampering Tehran’s efforts to curb the outbreak, have urged other countries and the United Nations to call on Washington to lift the sanctions. Washington has rejected easing the sanctions. Claim: Iran to use 20% of state budget to fight coronavirus.


Output: Iran is to allocate 20% of its annual state budget to fighting the coronavirus outbreak in the country, one of the worst-hit in the world, President Hassan Rouhani said on Saturday.